Molson Coors Shares Decline Despite EPS Beat as Revenue Falls Short

BenzingaBenzinga
|||1 min read
Key Takeaway

Molson Coors beat EPS expectations but missed revenue forecasts, declining 2.7% year-over-year. Stock fell 7% on weak guidance and revenue concerns.

Molson Coors Shares Decline Despite EPS Beat as Revenue Falls Short

Molson Coors Beverage Company delivered fourth-quarter earnings per share of $1.21, surpassing analyst expectations of $1.16. However, the brewer's quarterly revenue of $2.66 billion fell short of the Street consensus forecast of $2.72 billion, representing a 2.7% decline from the prior year period.

The mixed earnings report prompted a sharp market reaction, with the company's stock declining 7.02% in extended trading following the announcement. The revenue underperformance appears to have overshadowed the earnings-per-share beat, signaling investor concern about top-line growth momentum heading into the new fiscal year.

The company's forward guidance also weighed on investor sentiment, with management providing weaker revenue projections that contributed to the sell-off in after-hours trading.

Source: Benzinga

Back to newsPublished Feb 18

Related Coverage

GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
The Motley Fool

Dividend Powerhouses Coca-Cola and Tractor Supply Shine Amid Economic Uncertainty

Coca-Cola and Tractor Supply offer reliable dividend growth through economic uncertainty, with 60+ and 17 consecutive years of increases respectively.

KOTSCO
GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX
GlobeNewswire Inc.

Nektar Therapeutics Faces Class Action Over Failed Trial Data Disclosure

Pomerantz LLP filed securities fraud class action against Nektar Therapeutics, alleging false statements about clinical trial enrollment procedures led to trial failure and stock decline.

NKTR